• Skip to primary navigation
  • Skip to main content
  • Skip to footer
  • Email
  • Facebook
  • LinkedIn
  • YouTube

International Alliance of ALS/MND Associations

  • Members' Login
  • Contact
  • Join the Alliance
  • Donate
  • Understanding ALS/MND
    • What is ALS/MND
    • Genetics
    • Diagnosis
    • Glossary
    • Navigating the Community
  • Find a Member Association
  • Support for PALS & CALS
    • Fundamental Rights for People with ALS/MND and Caregivers
    • Research
      • Clinical Trial Registry Accuracy and Maintenance in ALS/MND Research
      • Open Science
        • Open Label Extension
      • Expanded Access
      • Understanding ALS/MND Research
      • Improving Regulatory Pathways
      • Right to Try
      • US FDA Orphan Drug Designation
      • Unproven Treatments
    • Advocacy
      • Advocacy Toolkit
      • Emergency Preparedness Toolkit
      • Equitable Access to Therapies
      • Recommendations for Trial Sponsors
    • Clinical Care
      • Genetic Counselling & Testing
      • Mental Health Support
      • Nursing and Symptom Management
      • Nutrition, Swallowing and Saliva
      • Activities of Daily Living and Occupational Therapy
      • Muscles, Mobility and Exercise
      • Respiratory Care
      • Speech and Communication
      • Voice Preservation
      • Support for Family & Caregivers
      • Technology
      • Global Clinic Locator
    • Drugs in Development
      • Masitinib
      • NurOwn
      • CNM-Au8
      • ILB
      • AstroRx
      • Neuronata-R / Lenzumestrocel
      • PrimeC
      • NP001
      • Pridopidine
      • SOD1 Therapies and Trials
      • C9orf72 Therapies and Trials
      • SPG302
      • Regulatory T Cell Enhancing Therapies
      • Ulefnersen
    • Approved Drugs
      • Nuedexta
      • Radicava / Edaravone
      • Riluzole / Tiglutik
      • Rozebalamin / Methylcobalamin
      • Tofersen / Qalsody
    • Drugs No Longer in Development
      • AMX0035
      • Reldesemtiv
      • Arimoclomol
      • TUDCA
      • CuATSM
  • Support for Health Professionals
    • Breaking the News in ALS/MND
    • R.A.C.E. to Diagnose ALS/MND
  • Programs & Events
    • Calendar of Events
    • Global Day
    • Alliance Meeting
    • Allied Professionals Forum
    • “Day in the Life Of” Suite
    • Alliance Webinars
    • ALS/MND Connect
    • March of Faces
    • Patient Fellows Program
    • Alliance Fellows
    • SEED Grant Program
    • Awards
      • Forbes Norris Award
      • Humanitarian Award
      • Allied Health Professional Award
      • Student Innovation Award
  • About
    • Who We Are
    • ALS/MND Health Literacy Map
    • Board of Trustees
    • Councils, Forums & Committees
      • Scientific Advisory Council
      • PALS and CALS Advisory Council
      • Advocacy and Public Policy Forum
      • Research Directors Forum
      • Governance Committee
      • Finance Committee
    • Staff
    • History
    • Newsletter Archive
  • Members
    • Member Registration
    • Forgot Password

Working Together for People Living with ALS/MND

The International Alliance of ALS/MND Associations brings together organizations from around the world to accelerate progress for people living with ALS/MND and their communities.
Find Resources See Our Members Join the Alliance
80+
Member Associations
40+
Countries Represented
30+
Years of Global Collaboration

 

Stay connected. Subscribe for the Alliance newsletter and updates on how to get involved.

 
This field is for validation purposes and should be left unchanged.

Join Us Online for Amsterdam

December 5–8, 2026

Join the global ALS/MND community online for the 2026 Alliance Meeting (December 5–6) and Allied Professionals Forum (December 7–8).

Participate in live sessions, ask questions, and access recordings afterward.

In-person registration is sold out, but virtual registration remains open at £150 per event.

Explore Programs & Register

Illustration of a DNA strand with check marks representing genetic recommendations.

New Genetics Recommendations

The Alliance’s international Genetics Task Force has published new global recommendations for genetic counselling and testing in ALS/MND, aimed at improving equitable access to genetic services worldwide.

Read the Recommendations

Illustration accompanying introductory information about ALS/MND.

New to ALS/MND? Start Here.

Plain-language information on what ALS/MND is, how it is diagnosed, and what to expect. Written for people living with ALS/MND, their families, and caregivers.

Understanding ALS/MND

Illustration accompanying the Fundamental Rights of People with ALS/MND.

Fundamental Rights of People with ALS/MND

The Fundamental Rights set out the care, support, and treatment that every person living with ALS/MND should be able to expect, wherever they live.

Read the Fundamental Rights

Upcoming Events

November 24: Annual General Meeting
December 5–6: Alliance Meeting, Amsterdam (Members Only). Register Online →
December 7–8: Allied Professionals Forum, Amsterdam. Register Online →

See All Events

The Faces Behind the Mission

These are the people at the centre of everything the Alliance does.

Be part of the global movement.

80+ associations. 40+ countries. One shared mission.

Become a Member

Footer

Stay connected to the global ALS/MND community.

Subscribe to receive our newsletter and updates on how to get involved across the Alliance network.

 
This field is for validation purposes and should be left unchanged.
  • Email
  • Facebook
  • LinkedIn
  • YouTube
Return to top of page

Contact | Disclaimer | Privacy Notice & Cookies | Sitemap

Copyright © 2026 The International Alliance of ALS/MND Associations. All rights reserved.


Registered in England: Charity Number 1079504 · Site built by graphics.coop · Powered by WordPress · Members' login